A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants
Clinical trial NCT02180659 · COMPLETED
Trial details
- NCT number
- NCT02180659
- Sponsor
- Titan Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2015-05-01
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.